AzTrials
AzTrials

Cleft Lip and PalateLUNIINCT03740841

Evaluation of the Effects of LUNII on Pre-operative Anxiety and on the Post-operative Period in Children With Cleft Lip and Palate Admitted for Alveolar Bone Graft: Pilot Study

A study testing Interactive story teller LUNII in people with Cleft Lip and Palate, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The literature on the effects of various devices on per-operative anxiety is scarce. There is currently no study on the effects of an interactive storyteller on per-operative anxiety in pediatric surgery. Read more about this study

Who is it for?
Ages 4 to 6 years
Conditions the study is for
Cleft Lip and Palate
What is being tested?
Interactive story teller LUNII
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteFrance
Study dates
8 Jan 2019to 8 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 4 to 6 years.
  • Alveolar bone graft with iliac crest donor site in children with unilateral or bilateral cleft lip and palate
  • Primary alveolar bone graft or first side when bilateral cleft
  • Followed at Necker since birth and operated according to the protocol used in the department.
  • Consent signed by the holder (or holders) of parental authority

Who cannot join

  • Medical care different from the usual protocol applied in the service (secondary surgery, age > 7 years)
  • Known psychomotor delay, associated rare syndrome or disease, known psychiatric disorders, other surgical procedures between hard palate closure and alveolar bone graft
  • Possession and/or prior use of LUNII by the child

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Necker-Enfants Malades

    Paris, 75015

Other trials in France

About this study

The literature on the effects of various devices on per-operative anxiety is scarce. There is currently no study on the effects of an interactive storyteller on per-operative anxiety in pediatric surgery.

The interactive story teller LUNII (available over the counter in France) would reduce pre-operative anxiety, with post-operative effects on pain and hospitalization time.

Read the detailed description

The literature on the effects of various devices on per-operative anxiety is scarce. There is currently no study on the effects of an interactive storyteller on per-operative anxiety in pediatric surgery.

The interactive story teller LUNII (available over the counter in France) would reduce pre-operative anxiety, with post-operative effects on pain and hospitalization time.

Patients admitted for an alveolar bone graft with an iliac donor site as part of the treatment of their cleft lip and palate will be include for two reasons:

  1. It is a homogeneous population - same condition, same treatment, same age at surgery, standardized procedure;
  2. It is a population with long individual medical histories and, potentially, subjected to significant surgery-related stress.

Patients will be randomized into two groups: with LUNII and without LUNII.

In the LUNII group, the interactive story teller LUNII will be delivered the day before surgery during the pre-operative medical visit.

Being tested
Interactive story teller LUNII
Keywords
Per-operative stress, per-operative anxiety, pediatric surgery
Medical subject headings
Cleft Lip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interactive story teller LUNIIBehavioural

    Use of the interactive story teller LUNII by the child from the pre-operative visit to the discharge.

Study groups in NCT03740841
Study groupRoleWhat they receive
LUNIIOtherThe interactive story teller LUNII is delivered to the child the day before surgery, during the usual pre-operative medical visit.
Receives: Behavioral: Interactive story teller LUNII
Without LUNIINo interventionUsual pre-operative visit.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Yale Preoperative Anxiety Scale (mYPAS )

    Questionnaire, completed in the operating room by an independent observer preferably without knowledge about the child, made of 22 items divided into 5 categories. The score ranges from 5 (minimum anxiety) to 20 (maximum anxiety)

    Measured: At the entrance into the operating room

  2. Yale Preoperative Anxiety Scale (mYPAS )

    Questionnaire, completed in the operating room by an independent observer preferably without knowledge about the child, made of 22 items divided into 5 categories. The score ranges from 5 (minimum anxiety) to 20 (maximum anxiety)

    Measured: At the time of anesthetic induction

  3. Number of hours spent with the interactive story teller LUNII before surgery

    Number of hours spent with the interactive story teller LUNII

    Measured: Day of surgery (D0)

Secondary outcomes (4)
  1. Analgesic administration

    Evaluation of analgesic administration after surgery during hospital stay

    Measured: Up to 1 week

  2. Visual Analogue pain Scale (EVA)

    Self-assessment of pain by a graduated ruler of 0 (no pain) at 100 millimeters (maximum pain imaginable), twice a day during hospitalization

    Measured: Up to 1 week

  3. Duration between the operation and the first survey

    Duration between the operation and the first survey

    Measured: Up to 1 week

  4. Length of hospitalization

    Length of hospitalization

    Measured: Up to 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2018
  2. Study start8 Jan 2019
  3. Primary completion8 Jan 2019
  4. Study completion8 Jan 2019

Why it stopped: Unsuccessful study

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03740841
Sponsor's protocol ID
K180306J
Other IDs
2018-A00758-47
Acronym
LUNII
Status last verified
Mar 2022
First submitted
2 Nov 2018
Last updated
25 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Interactive story teller LUNII in people with Cleft Lip and Palate, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 25 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Unsuccessful study). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Yale Preoperative Anxiety Scale (mYPAS ) (time frame: At the entrance into the operating room). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in